Literature DB >> 8459037

Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.

C Limas1, A Bigler, R Bair, P Bernhart, P Reddy.   

Abstract

AIMS: To evaluate the proliferative activity of urothelial neoplasms, compare it with that of the normal urinary tract epithelium, and determine its relation to morphological grade and presence of invasion.
METHODS: Multiple biopsy specimens from 53 individuals--eight normal controls, five patients with severe urothelial atypia, and 40 with transitional cell carcinomas (TCCs)--were studied using in vitro bromodeoxyuridine (BrdU) incorporation, Ki67 antigen expression, and quantitation of the nucleolar organiser regions (NORs).
RESULTS: The percentage of nuclei labelled by BrdU (BrdU index) correlated well with the percentage of nuclei expressing the Ki67 antigen (Ki67 index). These proliferation indices were very low (less than 0.1% in 60% of samples) in the urothelium of normal controls and the morphologically unremarkable epithelium of patients with TCCs. Non-invasive TCCs had increased proliferation (BrdU index 6.32 (SD 0.8)%, Ki67 index 5.04 (0.6)% but lagged behind the invasive tumours (BrdU 20.9 (3.2)%, Ki67 18.6 (2.8)%). The average NOR count was 1.57 (0.03) in morphological normal epithelium, which increased progressively with grade in non-invasive TCCs, but varied greatly in invasive tumours and did not correlate with the proliferation indices. The spectrum of values for both proliferation indices and NORs was particularly wide in grade 2 TCCs. Severe atypias without exophytic growth had an increase in BrdU and Ki67 indices comparable with that found in grade 3-4 invasive TCCs; these also had the highest NORs per nucleus.
CONCLUSIONS: The growth potential of urothelial neoplasms is an important indicator of their aggressive course. In particular, growth indices over 10% are strongly associated with the presence of invasion. Papillary grade 2 TCCs show heterogeneity in their growth characteristics which may relate to their diverse clinical course. The mitotic count underestimates the growth potential of papillary TCCs and the addition of proliferation indices such as BrdU incorporation or the Ki67 index may enhance the prognostic accuracy of conventional morphological grading.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8459037      PMCID: PMC501149          DOI: 10.1136/jcp.46.2.159

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  NATURAL HISTORY AND CLINICAL BEHAVIOR OF IN SITU CARCINOMA OF THE HUMAN URINARY BLADDER.

Authors:  M R MELAMED; N G VOUTSA; H GRABSTALD
Journal:  Cancer       Date:  1964-12       Impact factor: 6.860

2.  Nucleolar organizer regions in lymphomas.

Authors:  J Crocker; P Nar
Journal:  J Pathol       Date:  1987-02       Impact factor: 7.996

3.  Evaluation of nucleolar organizer region-associated proteins in breast malignancy.

Authors:  R Smith; J Crocker
Journal:  Histopathology       Date:  1988-02       Impact factor: 5.087

4.  Controlled silver-staining of nucleolus organizer regions with a protective colloidal developer: a 1-step method.

Authors:  W M Howell; D A Black
Journal:  Experientia       Date:  1980-08-15

5.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

6.  Proliferative activity of urothelium and tumors of renal pelvis, ureter, and urinary bladder evaluated by thymidine labeling.

Authors:  G Sufrin; J S Meyer; S A Martin; K Schechtman
Journal:  Urology       Date:  1984-03       Impact factor: 2.649

7.  Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.

Authors:  J Gerdes; F Dallenbach; K Lennert; H Lemke; H Stein
Journal:  Hematol Oncol       Date:  1984 Oct-Dec       Impact factor: 5.271

8.  The pathology of human bladder cancer.

Authors:  G H Friedell; G C Parija; G K Nagy; E A Soto
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

9.  Visualization of nucleolar organizer regions im mammalian chromosomes using silver staining.

Authors:  C Goodpasture; S E Bloom
Journal:  Chromosoma       Date:  1975-11-20       Impact factor: 4.316

10.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

Authors:  H G Gratzner
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

View more
  13 in total

1.  [Molecular markers in the diagnostics and therapy of urothelial cancer].

Authors:  C Protzel; O W Hakenberg
Journal:  Urologe A       Date:  2010-11       Impact factor: 0.639

2.  Three clonal types of urothelium with different capacities for replication.

Authors:  R Thangappan; E A Kurzrock
Journal:  Cell Prolif       Date:  2009-09-17       Impact factor: 6.831

Review 3.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

4.  Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine.

Authors:  M Sugiyama; A Woodman; T Sugino; S Crowley; K Ho; J Smith; Y Matsumura; D Tarin
Journal:  Clin Mol Pathol       Date:  1995-06

Review 5.  Somatic Mutation: What Shapes the Mutational Landscape of Normal Epithelia?

Authors:  Joanna C Fowler; Philip H Jones
Journal:  Cancer Discov       Date:  2022-07-06       Impact factor: 38.272

6.  Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors.

Authors:  C Limas; R Bair; P Bernhart; P Reddy
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

7.  Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.

Authors:  A Pich; L Chiusa; A Comino; R Navone
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).

Authors:  Johannes Breyer; Ralph M Wirtz; Mark Laible; Kornelia Schlombs; Philipp Erben; Maximilian Christian Kriegmair; Robert Stoehr; Sebastian Eidt; Stefan Denzinger; Maximilian Burger; Arndt Hartmann; Wolfgang Otto
Journal:  Virchows Arch       Date:  2016-08-11       Impact factor: 4.064

9.  Lymphatic vessel density and function in experimental bladder cancer.

Authors:  Marcia R Saban; Rheal Towner; Nataliya Smith; Andrew Abbott; Michal Neeman; Carole A Davis; Cindy Simpson; Julie Maier; Sylvie Mémet; Xue-Ru Wu; Ricardo Saban
Journal:  BMC Cancer       Date:  2007-11-29       Impact factor: 4.430

10.  Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.

Authors:  P Lipponen; M Eskelinen
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.